LAUNXP Biomedical Co., Ltd (6876.TWO)

TWD 18.85

(-0.26%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020
Revenue 11 Thousand - - 800 Thousand
Cost of Revenue - - - 422 Thousand
Gross Profit 11 Thousand - - 378 Thousand
Operating Expenses 81.06 Million 43.62 Million 34.82 Million 29.12 Million
Selling, General and Administrative Expenses 37.38 Million 23.9 Million 8.18 Million 4.98 Million
Research and Development Expenses 43.67 Million 19.71 Million 15.14 Million 16.22 Million
Other Expenses 22 Thousand 6000.00 1000.00 -
Cost and Expenses 81.06 Million 43.62 Million 34.82 Million 29.55 Million
Operating Income -80.78 Million -43.41 Million -34.68 Million -28.66 Million
Interest Expense 167 Thousand 195 Thousand 60 Thousand 89 Thousand
Income Tax Expense - - - -
Earnings before Tax -80.94 Million -43.61 Million -34.74 Million -28.75 Million
Net Income -80.94 Million -43.61 Million -34.74 Million -28.75 Million
Earnings Per Share Basic -4.49 -2.42 -2.06 -2.67
Earnings Per Share Diluted -4.49 -2.42 -2.06 -2.67
Weighted Average Shares Outstanding 18.02 Million 18.02 Million 16.86 Million 10.77 Million
Weighted Average Shares Outstanding (Diluted) 18.02 Million 18.02 Million 16.86 Million 10.77 Million
Gross Margin 1.00 - - 0.47
EBIT Margin -7124.36 - - -33.83
Profit Margin -7359.00 - - -35.95
EBITDA -78.36 Million -41.06 Million -33.08 Million -27.06 Million
Earnings Before Tax Margin -7343.82 - - -35.84

Income Statement Charts